Hypoventilation and progressive encephalopathy in a neonate with MTHFR deficiency.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
04 Jan 2022
Historique:
pmc-release: 04 01 2024
entrez: 5 1 2022
pubmed: 6 1 2022
medline: 7 1 2022
Statut: epublish

Résumé

Methylenetetrahydrofolate reductase (MTHFR) deficiency is a rare autosomal recessive inherited inborn error of metabolism, which presents with various severity depending on the level of residual enzyme activity. In neonates, it can present with recurrent hypoventilation episodes, persistent encephalopathy with or without microcephaly. MTHFR deficiency also results in hyperhomocysteinemia, homocystinuria and hypomethionemia. We report a male neonate with severe MTHFR deficiency presenting to us on third week of life with progressive encephalopathy, microcephaly, seizures, central hypoventilation. There was similar history in the previous sibling. The patient's blood lactate, ammonia, tandem mass spectrometry for amino acids and acyl carnitine were normal. He remained encephalopathic with progressive increase in need of respiratory support in spite of supportive treatment and metabolic cocktail consisting of riboflavin, pyridoxine, coenzyme Q and carnitine. This neonate had novel homozygous mutation, which results in MTHFR deficiency. In newborn with hypoventilation or recurrent apnoea with encephalopathy and microcephaly, MTHFR deficiency should be considered as a differential diagnosis. Mutation study helps in confirming diagnosis; however, extended newborn metabolic screening with homocysteine level could help in early diagnosis of these cases.

Identifiants

pubmed: 34983810
pii: 15/1/e246431
doi: 10.1136/bcr-2021-246431
pmc: PMC8728471
pii:
doi:

Substances chimiques

MTHFR protein, human EC 1.5.1.20
Methylenetetrahydrofolate Reductase (NADPH2) EC 1.5.1.20

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kiran Vemireddy (K)

Neonatology, Rainbow Children's Hospital, Hyderabad, Telangana, India.

Nalinikanta Panigrahy (N)

Neonatology, Rainbow Children's Hospital, Hyderabad, Telangana, India nalini199@gmail.com.

Lokesh Lingappa (L)

Pediatric Neurology, Rainbow Children's Hospital, Hyderabad, Telangana, India.

Dinesh Chirla (D)

Neonatology, Rainbow Children's Hospital, Hyderabad, Telangana, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH